“Predible Lung helps validate and pre-help in picking abnormalities. There’s a quality augmentation,” says Bharat Aggarwal, director, radiology services, Max Healthcare, with which Predible has a tie-up. Predible Lung is live in more than 20 sites across India, says Vaidya.
They have raised around $500,000 in funding and are in the process of getting global regulatory approvals to expand in the Europe and US markets. “They are anchoring themselves in India but being global in their approach,” says Milind Shah, venture partner, health care, Unitus Ventures, an investor.